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Abstract
c-Jun N-terminal kinase (JNK) plays a key role in the regulation of neuronal apoptosis. Pre-
vious studies have revealed that forkhead transcription factor (FOXO3a) is a critical effector
of JNK-mediated tumor suppression. However, it is not clear whether the JNK/FOXO3a
pathway is involved in neuronal apoptosis in the developing rat brain after hypoxia-ischemia
(HI). In this study, we generated an HI model using postnatal day 7 rats. Fluorescence
immunolabeling and Western blot assays were used to detect the distribution and expres-
sion of total and phosphorylated JNK and FOXO3a and the pro-apoptotic proteins Bim and
CC3. We found that JNK phosphorylation was accompanied by FOXO3a dephosphoryla-
tion, which induced FOXO3a translocation into the nucleus, resulting in the upregulation of
levels of Bim and CC3 proteins. Furthermore, we found that JNK inhibition by AS601245, a
specific JNK inhibitor, significantly increased FOXO3a phosphorylation, which attenuated
FOXO3a translocation into the nucleus after HI. Moreover, JNK inhibition downregulated
levels of Bim and CC3 proteins, attenuated neuronal apoptosis and reduced brain infarct
volume in the developing rat brain. Our findings suggest that the JNK/FOXO3a/Bim path-
way is involved in neuronal apoptosis in the developing rat brain after HI. Agents targeting
JNK may offer promise for rescuing neurons from HI-induced damage.
Introduction
c-Jun N-terminal kinase (JNK), a member of the mitogen-activated protein kinase (MAPK)
family, has been shown to be activated in several models of neuronal apoptosis induced by exci-
totoxicity, trophic factor withdrawal and ischemia [1]. Inhibition of JNK signaling through
genetic and pharmacological approaches protects neurons against several different apoptotic
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stimuli [2,3,4]. Although JNK has been established as a key player in neuronal apoptosis, the
mechanisms that link JNK to neuronal apoptosis have not been clearly defined.
Mammalian forkhead transcription factor (FOXO) is a critical effector of JNK-mediated
tumor inhibition [5,6]. The FOXO family consists of four members: FOXO1a; FOXO3a;
FOXO4; and FOXO6 [5]. Among them, FOXO3a is closely related to cellular apoptosis, aging,
proliferation, metabolism, differentiation and tumorigenesis [7,8,9,10]. FOXO3a activity is reg-
ulated at different levels, and its phosphorylation status plays a pivotal role in regulating its
subcellular localization and transcriptional activities [11]. When FOXO3a is phosphorylated
by protein kinase B (Akt), FOXO3a binds 14-3-3 protein and is retained in the cytoplasm. Con-
versely, FOXO3a dephosphorylation results in its translocation from the cytoplasm to the
nucleus [12,13].
FOXO3a regulation involves multiple pathways, including the pro-survival PI3K/Akt path-
way and the pro-apoptotic JNK pathway [9]. JNK regulates the activities of FOXO3a at differ-
ent levels [14,15]. Activation of JNK in vitro leads to phosphorylation of 14-3-3 at serine 184,
which in turn causes dissociation of FoxO3a from 14-3-3 in the cytoplasm, resulting in nuclear
localization of FOXO3a [16]. This translocation induces FOXO3a target genes, such as the
pro-apoptotic protein Bcl-2-interacting mediator of cell death (Bim). Bim has been shown an
important mediator of neuronal death in neonatal hypoxia-ischemia models [17]. As a member
of the Bcl-2 family, Bim activation can directly interact with pro-apoptotic factors, such as Bax,
to form a complex and then translocate into the mitochondrial membrane [18]. This complex
promotes the release of cytochrome C and activates caspase-dependent apoptosis [18]. JNK
also regulates FOXO3a activities by affecting MST1 activation [6]. Additional mechanisms
governing FOXO3a function by JNK might be related to regulation of Akt or that of some
phosphates activities which mediate FOXO3a dephosphorylation [19,20]. However, it is
unclear whether JNK is involved in FOXO3a activation in the developing rat brain after HI.
Based on previous studies, we hypothesized that the JNK/FOXO3a/Bim pathway is involved in
neuronal apoptosis in the developing rat brain after HI. To test this hypothesis, we generated




All animal research was approved by the Sichuan University Committee on Animal Research.
Female Sprague–Dawley rats with mixed gender litters were acquired from the animal center
of Sichuan University (Chengdu, China). The mother was provided food and water and housed
in a temperature- and light-controlled facility until the pups were 7 days old. For the HI model,
we used a previously described method [21]. Briefly, each pup was anesthetized with halothane.
With the pup supine, the right common carotid artery (CCA) was exposed and permanently
ligated with a 7–0 silk suture through a midline cervical incision. After CCA ligation, the pups
were returned to the dam for 1 h to recover from anesthesia. A duration of 2.5 h of hypoxia
(8% O2/92% N2) was used to produce the HI injury. Sham controls received halothane anesthe-
sia and exposure of the CCA without hypoxia and ligation of the CCA. The rat brains from
sham controls and from 0.5, 6, 24, 48 and 72 h after HI were collected for experiments.
Intracerebroventricular injection of DMSO and JNK inhibitors
AS601245, a highly specific JNK inhibitor, blocks JNK activity by binding to its ATP-binding
site. Pups were anesthetized with 2.5% halothane and intracerebroventricularly infused with
vehicle (dimethyl sulfoxide [DMSO], Sigma-Aldrich, USA) or 150 nmol of AS601245 (Alexis
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Biochemicals, Lausen, Switzerland) dissolved in DMSO into the right cerebral hemisphere
30 minutes prior to HI using a 30-gauge needle with a 5-μL Hamilton syringe (infusion rate
1 μL/min) injections. The AS601245 dose (150 nmol in DMSO) was chosen according to a pre-
vious report [22]. The location of each injection was 2 mm rostral, 1.5 mm lateral to bregma,
and 2.5 mm deep to the skull surface.
Fluorescence immunolabeling
To delineate the cellular localization of p-JNK and Bim, double immunolabeling was per-
formed with neuron-specific (NeuN) and astrocytic (GFAP) markers. Paraffin-embedded sec-
tions (n = 5) were used for fluorescence double immunolabeling, as described previously [22].
The sections were incubated overnight at 4°C in a mixture of two primary antibodies raised in
separate species: rabbit polyclonal antibodies against p-JNK (Thr183/Tyr185; Cell Signaling,
1:100) or Bim (Abcam, 1:200); and mouse monoclonal antibodies against NeuN (Millipore,
1:100) or GFAP (Millipore, 1:100). The sections were then incubated with a 1:80 dilution of a
secondary antibody, either FITC- or TRITC-conjugated anti-rabbit or anti-mouse IgG (Sigma
Aldrich Inc., USA). The nucleus was stained with 4',6-diamidino-2-phenylindole (DAPI).
Images were captured using NIH Image in both the FITC and TRITC channels.
Western blot analysis
The isolated cortex and hippocampus from the right hemisphere were dissected (n = 5 per
group). The samples from the cortex were pooled and processed as described previously [23].
Briefly, cortices were homogenized in ice-cold lysis buffer containing cytosol extraction buffer,
consisting of N-[2-hydroxyethyl] piperazine-N0-[2-ethanesulfonic acid] (HEPES; pH 7.9; 10
mmol/L), KCL (10 mmol/L), ethylenediaminetetraacetic acid (EDTA; 0.1 mmol/L), ethylene
glycol tetraacetic acid (EGTA; 0.1 mmol/L), dithiothreitol (DTT; 1 mmol/L), phenylmethane-
sulfonyl fluoride (PMSF; 0.5 mmol/L), the protease inhibitors aprotinin (5 μg/mL) and leupep-
tin (5 μg/mL), and a phosphokinase inhibitor (10 μg/mL). Lysates were centrifuged at 12,000 g
for 30 min at 4°C. Cytosolic and nuclear proteins were purified as described previously fol-
lowed the Nuclear and Cytoplasmic Extraction Reagents (Pierce, Cat. No.78833). Briefly, cyto-
plasmic extracts were separated at maximum speed in a microcentrifuge (~16,000 × g) for 5
minutes. Then vortex the insoluble (pellet) fraction and centrifuge the tube at maximum speed
(~16,000 × g) in a microcentrifuge for 10 minutes. Protein concentrations were determined
using a BCA protein assay kit (Pierce) with bovine serum albumin (BSA) as the standard. Pro-
tein samples (100 μg per lane) were separated on 8% SDS-polyacrylamide gels, as described
previously [23]. The proteins were then transferred to polyvinylidene fluoride (PVDF) mem-
branes. The membranes were blocked in 5% BSA in TBS containing 0.05% Tween-20 for 1 h at
room temperature with rotation. The membranes were incubated for 1 h at room temperature
with the following antibodies: rabbit anti-JNK monoclonal antibody (Cell Signaling, 1:1000);
rabbit anti-p-JNK (Thr183/Tyr185) polyclonal antibody (Cell Signaling, 1:1000); rabbit anti-
Akt polyclonal antibody (Cell Signaling, 1:400); rabbit anti-p-Akt (Ser473) monoclonal anti-
body (Cell Signaling, 1:400); rabbit anti-FOXO3a polyclonal antibody (Cell Signaling, 1:800);
rabbit anti-p-FOXO3a (Ser253) polyclonal antibody (Cell Signaling, 1:800); rabbit anti-Bim
polyclonal antibody (Abcam, 1:200); and rabbit anti-CC3 polyclonal antibody (Millipore,
1:100) overnight at 4°C. A rabbit anti-GAPDH polyclonal antibody (Sigma, 1:2000) was used
as an internal loading control. The membranes were then incubated with peroxidase-
conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology, 1:3000) in blocking solution for
1 h. The signals of the bound antibodies were visualized by enhanced chemiluminescence
(Pierce, Rockford, IL). NIH Image was used to quantify the densities of the protein signals on
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X-ray films after scanning. The protein levels were normalized to GAPDH as a loading control.
The relative optical density of the protein bands was measured following subtraction of the
film background.
In vitro kinase assay for JNK
JNK activity was measured using a specific kit (Cell Signaling, USA), and glutathione S-
transferase-Jun fusion peptides served as the substrate for JNK, as previously described [22]. In
brief, cortex tissue lysates (200 μg) were incubated overnight at 4°C with glutathione S-
transferase-Jun fusion protein beads. After washing, the beads were resuspended in kinase
buffer containing ATP, and the kinase reaction was allowed to continue for 30 minutes at
30°C. The reactions were halted by adding polyacrylamide gel electrophoresis sample loading
buffer. Proteins were separated by electrophoresis on 10% SDS-PAGE, transferred onto PVDF
membranes, and incubated with an anti-phospho-c-Jun (Ser63) antibody (Cell Signaling,
1:1000). Immunoreactivity was detected using enhanced chemiluminescence.
Evaluation of neuropathological injury
Brain injury was evaluated by detecting cell apoptosis as well as calculating infarct volume.
Apoptotic cell death was detected using an In Situ Cell Death Detection Kit (Millipore, Bil-
lerica, MA, USA) according to the manufacturer's instructions. Briefly, sections were deparaffi-
nized in xylene, rehydrated through graded ethanol, treated with 0.1 M citrate solution and 3%
hydrogen peroxide at room temperature for 10 min and then treated with proteinase K (20 μg/
mL) for 7 min. Sections were washed in PBS and incubated at 37°C for 1 h with Fluorescein-
FragEL Labeling TdT enzyme. The total cell populations were stained with DAPI. As negative
controls, alternate sections were processed in parallel without TdT enzyme.
Brain infarct volume was measured through triphenyltetrazolium chloride (TTC) staining
with the method described by Liu et al [24]. Briefly, brains were chilled at −80°C for 4 min.
Then five of 2 mm coronal sections were made from the olfactory bulb to the cerebellum and
then stained with 1.5% TTC (Sigma, USA) at 37°C for 15 min. After staining, the sections were
scanned and measured using image analysis software (NIHimage, USA) to determine the
ischemic infarct volume in a blinded manner. Total infarct area was multiplied by the thickness
of the brain sections to obtain infarct volume as being previously described [25]. In order to
minimize the error introduced by edema, an indirect method for calculating infarct volume
was used [26]. The non-infarcted area in the ipsilateral hemisphere was subtracted from that in
the contralateral hemisphere, and infarct volume was calculated using the following formula:
corrected percentage of infarct volume = (contralateral hemispheric volume-ipsilateral non-
infarcted volume) /contralateral hemispheric volume.
Statistics
The data are represented as the mean±standard deviation (SD). ANOVAs with Bonferroni/
Dunnett post hoc tests were performed for multiple comparisons. Significant differences
between the two groups were compared using t tests. P<0.05 was considered significant.
Results
Expression and distribution of p-JNK and JNK after HI
To quantify p-JNK (active JNK) and total JNK expression after HI in this model, we measured
p-JNK and total JNK protein expression levels through Western blot analysis. Total protein
was isolated from sham controls as well as from rats at 0.5, 6, 24, 48 and 72 h after HI (each
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group, n = 5). We found that the total JNK protein was not obviously changed at the different
time points compared with sham controls (Fig 1A and 1B). However, p-JNK protein was tem-
porarily reduced at 0.5 h, obviously increased from 6 to 24 h, reached the highest levels at 48 h
and remained at a high level at 72 h after HI (Fig 1A and 1B). After normalization to GAPDH,
there was a 2.5-fold increase in p-JNK at 48 h after HI compared with sham controls (Fig 1B).
Because p-JNK is highly expressed at 48 h after HI, double immunofluorescence labeling
was performed to determine the cellular localization of p-JNK at 48 h after HI (n = 5). Double
staining with the neuronal-specific marker NeuN and the astrocyte-specific marker GFAP
showed that p-JNK-immunoreactive cells mainly colocalized with neurons (Fig 1C) and astro-
cytes (Fig 1D).
HI promotes FOXO3a dephosphorylation, which induces FOXO3a
translocation into the nucleus and upregulates levels of Bim and CC3
proteins
Because FOXO3a has been identified as a principal substrate of JNK in tumor inhibition [5,6],
we questioned whether FOXO3a was altered after HI. We quantified both the total FOXO3a
and p-FOXO3a protein expression. We found that the total FOXO3a was not markedly
changed at the indicated time points (Fig 2A and 2B). However, p-FOXO3a levels decreased
from 0.5 to 48 h and returned to baseline at 72 h after HI (Fig 2A and 2B). After normalization
to GAPDH, there was an approximately 42% decrease in p-FOXO3a at 48 h after HI compared
with the sham controls (Fig 2B). The decrease in p-FOXO3a levels indicates that there was an
increase in FOXO3a dephosphorylation.
FOXO3a dephosphorylation has been reported to promote FOXO3a translocation into the
nucleus in cultured cerebellar granule neurons deprived of growth factors [12, 13]. We ques-
tioned whether HI-induced FOXO3a dephosphorylation would promote FOXO3a transloca-
tion into the nucleus. To answer this question, we extracted the nuclear and cytosolic proteins
from the cortices and quantified FOXO3a expression separately in the nucleus and cytoplasm
using Western blot analysis (Fig 2C). We found that the nuclear protein of FOXO3a obviously
increased from 0.5 to 48 h in a time-dependent manner, and it remained at a high level at 72 h
(Fig 2C and 2D). After normalization to GAPDH expression, we found that there was an
approximately 3.3-fold increase in nuclear protein levels of FOXO3a at 48 h after HI compared
with the sham controls (Fig 2D). In contrast, cytoplasmic protein levels evidently decreased
from 0.5 to 72 h (Fig 2C and 2D). After normalization to GAPDH expression, there was an
approximately 77% decrease in the cytosolic protein levels of FOXO3a at 48 h after HI com-
pared with the sham controls (Fig 2D).
To determine whether Bim, a downstream target gene of FOXO3a, was regulated by
FOXO3a translocation into the nucleus, we quantified Bim protein expression using Western
blot analysis. We found that Bim protein was obviously induced at 0.5 h, peaked at 6 h,
returned to baseline at 24 h, and then increased again at 48 h, which lasted through to 72 h (Fig
2E and 2F). There were approximately 2.4-fold and 1.9-fold increases in Bim expression at 6
and 48 h after HI, respectively, compared with the sham controls (Fig 2F).
Cleaved caspase-3 (CC3) is a key executor of the apoptosis cascade reaction. We quantified
CC3 protein expression through Western blot analysis. We found that CC3 protein was obvi-
ously induced at 6 h, peaked at 24 and 48 h, and remained at a high level at 72 h (Fig 2E and
2F). There was an approximately 3.7-fold increase in the CC3 protein level at 48 h after HI
compared with the sham controls (Fig 2F).
Double immunofluorescence labeling was performed to determine the cellular localization
of Bim after HI. Because Bim is highly expressed 48 h after HI, paraffin-embedded sections at
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Fig 1. Expression and distribution of p-JNK and JNK proteins in the P7 rat brain after HI as detected byWestern blot analysis and fluorescence
immunolabeling. Samples were obtained from the cortex. Equal levels of protein samples (100 μg) were loaded, and GAPDH served as a loading control.
The values are expressed as the relative optical density and represented as the mean±SD (n = 5). Total JNK protein was not obviously changed at different
time points compared with sham controls (A). However, p-JNK protein levels transiently decreased at 0.5 h, increased at 6 and 24 h, peaked at 48 h, and
lasted until 72 h (A). The JNK and p-JNK expression levels in the HI groups and sham controls were quantified. The data were obtained by densitometry and
normalized to GAPDH. *p<0.05, **p<0.01 compared with the sham control (B). (HI, hypoxia-ischemia). The cell type specificity of p-JNK with double
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48 h after HI were used (n = 5). As shown in Fig 2, double staining with the neuronal-specific
marker NeuN showed that Bim-immunoreactive cells mainly colocalized with neurons in the
injured cortices (Fig 2G).
JNK inhibitor AS601245 rescues the decrease in p-FOXO3a and
attenuates FOXO3a translocation into nucleus after HI
To further determine whether JNK was involved in FOXO3a regulation after HI, we utilized
AS601245, a highly specific JNK inhibitor, which blocked JNK activity by binding to its ATP
binding site [22]. In this study, 150 nM of AS601245 was intracerebroventricularly injected
into the injured cerebral hemisphere 30 minutes prior to HI according to a previous report
[22]. In vitro kinase assays showed that there was 2.4-fold increase in the levels of phosphory-
lated GST-c-Jun (p-GST-c-Jun) 48 h after HI compared with sham controls (Fig 3A and 3B),
which indicated that HI induced the upregulation of JNK activity. JNK activity was reduced to
41% of the level in the AS601245-treated cortex compared with the DMSO-treated cortex (Fig
3A and 3B), which indicated that JNK activity was blocked by AS601245.
We next investigated whether AS601245 pretreatment affected FOXO3a expression and
phosphorylation. We found that AS601245 pretreatment significantly increased the expression
of p-FOXO3a at 48 h after HI compared with the DMSO controls (Fig 3C and 3D). After nor-
malization to GAPDH, we found that there was approximately a 2.9-fold increase of p-
FOXO3a protein at 48 h (Fig 3D). However, total FOXO3a was not markedly changed at 48 h
after HI (Fig 3C and 3D).
Because AS601245 pretreatment can rescue the decrease of p-FOXO3a after HI, we further
investigated whether JNK was involved in the regulation of FOXO3a translocation from the
cytoplasm to the nucleus. We found that FOXO3a was upregulated in the nucleus but downre-
gulated in the cytoplasm 48 h after HI (Fig 3E and 3F). However, AS601245 treatment obvi-
ously reduced the FOXO3a nuclear protein and increased the FOXO3a cytosolic protein
compared with the DMSO-treated cortex (Fig 3E and 3F). After normalization to GAPDH
expression, we found that AS601245 blocked approximately 58% of the FOXO3a nuclear pro-
tein (Fig 3F). Meanwhile, there was an approximately 2.9-fold increase in FOXO3a cytosolic
protein at 48 h after HI (Fig 3F) in the AS601245-treated cortex compared with the DMSO-
treated cortex.
There is crosstalk between the pro-apoptotic JNK pathway and the pro-survival Akt path-
way at multiple levels [27,28]. To further investigate whether the regulation of FOXO3a by
JNK after HI is related to Akt, we examined the expression of p-Akt and Akt protein after JNK
was blocked with AS601245 using Western blot analysis. We found that both the p-Akt and
total Akt levels were not changed at 48 h in the AS601245-treated cortex compared with the
DMSO-treated cortex (Fig 3G and 3H), suggesting that the regulation of FOXO3a by JNK is
independent of Akt in this study.
JNK inhibitor AS601245 decreases levels of Bim and CC3 proteins and
reduces brain damage after HI
To further understand whether JNK inhibition could regulate a pro-apoptotic protein Bim, one
of the FOXO3a target genes, and CC3 in this model, we used Western blot assays to detect the
fluorescent immunolabeling (n = 5). p-JNK, the neuron-specific marker NeuN and the astrocyte-specific marker GFAP were visualized using a p-JNK
antibody followed by a FITC-conjugated secondary antibody (green) and NeuN or GFAP followed by a TRITC-conjugated secondary antibody (red). The
nucleus was stained by DAPI (blue). p-JNK (C, D) immunoreactivity colocalized to neurons (yellow) and astrocytes (yellow) in the ischemic cortex. Scale bar,
50 μm.
doi:10.1371/journal.pone.0132998.g001
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Fig 2. HI promotes FOXO3a dephosphorylation, which induces FOXO3a translocation into the nucleus and upregulates the expression of Bim and
CC3. Samples were obtained from the cortex. Equal levels of protein samples (100 μg) were loaded, and GAPDH served as a loading control. The values are
expressed as the relative optical density and represented as the mean±SD (n = 5). Total FOXO3a levels remained unchanged at the indicated time points
(A). However, p-FOXO3a levels decreased from 0.5 to 48 h and returned to baseline at 72 h after HI (A). Nuclear FOXO3a protein levels obviously increased
from 0.5 to 48 h in a time-dependent manner and remained at a high level at 72 h (C). In contrast, the cytoplasmic protein level decreased from 0.5 to 72 h
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expression of Bim and CC3 protein after JNK was blocked with AS601245. We found that the
Bim and CC3 protein levels were significantly reduced at 48 h in the AS601245-treated cortex
compared with the DMSO-treated cortex (Fig 4A and 4B). After normalization to GAPDH
expression, we found that there was approximately a 43% decrease in Bim protein levels at 48 h
(Fig 4B) and approximately a 61% decrease in CC3 protein levels at 48 h (Fig 4B) in the
AS601245-treated cortex compared with the DMSO-treated cortex.
Because the blockade of JNK activity by AS601245 decreased the expression of Bim and
CC3, we investigated whether cellular apoptosis could be blocked by the downregulation of
Bim and CC3. Brain sections from sham controls and 0.5, 6, 24, 48 and 72 h after HI as well as
from AS601245-treated sections were examined for cellular apoptosis using TUNEL staining
(each group, n = 5). We found that TUNEL-positive cells were not detected in the sham con-
trols (Fig 4C) as well as at 0.5 h (data not shown) after HI. However, the number of positive
cells increased at 6 h (data not shown) and 24 h (data not shown) and peaked at 48 h (Fig 4D)
after HI. Meanwhile, we found that AS601245 pretreatment obviously reduced cellular apopto-
sis at 48 h after HI (Fig 4F), and decreased the infarct volume 7 days after HI significantly (Fig
4H), compared with the DMSO controls (Fig 4E and 4H,). The cell apoptosis index in the
AS601245-treated brain cortex was decreased by 59% compared with the DMSO-treated brain
cortex (Fig 4G). The infarct volume in the AS601245-treated brain was decreased by 58% com-
pared with the DMSO controls (Fig 4I).
Discussion
In this study, we first showed that the JNK/FOXO3a/Bim pathway was involved in neuronal
apoptosis in the developing rat brain after HI. First, we found that JNK phosphorylation and
the reduction of p-FOXO3a preceded neuronal apoptosis, suggesting that JNK phosphoryla-
tion and FOXO3a dephosphorylation were involved in mediating HI-induced brain damage.
Second, FOXO3a dephosphorylation induced FOXO3a translocation from the cytoplasm into
the nucleus, which upregulated levels of pro-apoptosis proteins, such as Bim and CC3. Third,
pretreatment with AS601245, a highly specific JNK inhibitor, clearly increased FOXO3a phos-
phorylation, leading to a decrease in FOXO3a translocation from the cytoplasm to the nucleus
and levels of Bim and CC3 proteins. Finally, JNK inhibition with AS601245 reduced neuronal
apoptosis and brain infarct volume after HI.
JNK is an important stress-responsive kinase that is activated by various forms of brain
insults. The activated form of JNK is p-JNK. After phosphorylation, activated JNK can activate
its downstream transcriptional factors, triggering the expression of pro-apoptotic target gene
Bim, and inducing cell apoptosis [4]. In addition to Bim, JNK is involved in regulation of 14-3-
3 protein phosphorylation [3]. Serine phosphorylation of 14-3-3 protein promotes transloca-
tion of Bax to mitochondria that is essential process to initiate mitochondrial apoptosis [3].
Using double immunofluorescence labeling, we found that p-JNK (active JNK) was mainly
expressed in the neurons and astrocytes in the injured cortex (Fig 1C and 1D). The levels of p-
JNK decreased temporarily at 0.5 h and obviously increased from 6 to 72 h after HI (Fig 1A
and 1B), indicating that HI facilitated JNK phosphorylation and increased its activity. Our
(C). Bim protein was obviously induced at 0.5 h, peaked at 6 h, returned to baseline at 24 h, and then increased again at 48 h and lasted through to 72 h (E).
CC3 protein was obviously induced at 6 h, peaked at 24 and 48 h, and remained at a high level at 72 h (E). Total FOXO3a, p-FOXO3a, nuclear and cytosolic
proteins of FOXO3a, Bim and CC3 expression in the HI groups and sham controls were quantified. The data were obtained by densitometry and normalized
to GAPDH. **p<0.01 compared with the sham control (B, D and F). (HI, hypoxia-ischemia). The cell type specificity of Bim with double fluorescent
immunolabeling (n = 5). Bim and the neuronal specific marker NeuN were visualized using an anti-Bim antibody followed by a FITC-conjugated secondary
antibody (green) and an anti-NeuN antibody followed by a TRITC-conjugated secondary antibody (red). The nucleus was stained with DAPI (blue). Bim (G)
immunoreactivity colocalized to neurons (yellow) in the ischemic cortex. Scale bar, 50 μm.
doi:10.1371/journal.pone.0132998.g002
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Fig 3. JNK inhibitor AS601245 significantly rescued the decrease in p-FOXO3a and attenuated FOXO3a translocation into nucleus after HI with no
influence on p-Akt. Samples were obtained from the cortex. A JNK in vitro kinase assay showed a significant increase in phosphorylated GST-c-Jun (p-
GST-c-Jun) in the cortex at 48 h after HI compared with sham controls (A). AS601245 pretreatment effectively blocked JNK activity at 48 h after HI compared
with the DMSO-treated cortex (A). p-FOXO3a protein levels significantly increased with AS601245 pretreatment at 48 h after HI compared with the DMSO-
treated cortex (C). However, total FOXO3a levels remained unchanged (C). Nuclear FOXO3a protein was reduced in the AS601245-treated cortex
compared with the DMSO-treated cortex (E). In contrast, the cytosolic protein was increased in the AS601245-treated cortex compared with the DMSO-
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findings are in accordance with previous reports [29]. Although there are contradicting reports
that p-JNK increases at 0.5 h after global ischemia in an adult rat model [3], we believe that
these discrepancies may be due to differences in the animal age and the ischemic model.
Previous studies have revealed that JNK regulates the FOXO3a activity at different levels and
in multiple modes [14,15]. Phosphorylation/dephosphorylation play a key role in the regulation
of FOXO3a subcellular localization and transcriptional activities [11]. Acetylation of FOXO pro-
teins has been described as important for their activity as well. Acetylation of FOXO proteins by
acetylases such as CBP and p300 inhibits their activity and increases the response of them to oxi-
dative stress [9]. JNK also regulates FOXO3a activities by effecting MST1 activation [6]. We
found that p-FOXO3a decreased at 0.5 h and was maintained at a low level at 48 h after HI
(Fig 2A and 2B). Because p-FOXO3a, the inactive form of FOXO3a, decreased and the total
FOXO3a level was not changed, dephosphorylated FOXO3a, the active form of FOXO3a,
increased. Once FOXO3a dephosphorylation occurs, FOXO3a translocation from the cytoplasm
into the nucleus is facilitated [12,13]. We found that translocation of FOXO3a into the nucleus
occurred along with the reduction in the expression of p-FOXO3a at 0.5 h after HI (Fig 2C and
2D). Meanwhile, the expression of the pro-apoptotic protein Bim increased and peaked at 6 h
after HI (Fig 2E and 2F), which was earlier than the peak time for neuronal apoptosis (Fig 4D).
The expression of CC3 peaked at 24 and 48 h, which was in accordance with the peak time for
the neuronal apoptosis. (Fig 2E, Fig 4D). These findings demonstrated that the reduction of p-
FOXO3a promoted the translocation of FOXO3a into the nucleus and induced the expression
of the pro-apoptotic proteins Bim and CC3, leading to neuronal apoptosis after HI. We also
found that Bim expression was not entirely in accordance with the nuclear translocation of
FOXO3a at 24 h after HI because nuclear FOXO3a protein remained at a high level, whereas
Bim protein levels returned to baseline. One possible reason for this discrepancy may be due to
the degradation of Bim by the ubiquitin-proteasome pathway as previously reported [30].
Contrary to the pro-apoptotic JNK pathway, Akt inhibits cellular apoptosis through the
negative regulation of FOXO3a activities [12,31]. There is crosstalk between the pro-apoptotic
JNK pathway and pro-survival Akt pathway at multiple layers and levels [27, 28]. In this study,
the phosphorylation of JNK after HI occurred along with the reduced expression of p-FOXO3a
and the translocation of FOXO3a into the nucleus. Therefore, we wished to determine whether
JNK participates in the regulation of FOXO3a-mediated neuronal apoptosis. We injected the
JNK-specific inhibitor AS601245 into the rat brain 30 minutes prior to HI. AS601245 protects
neurons from injury in the adult global ischemic model, neonatal hypoxia-ischemia brain dam-
age (HIBD) model and white matter injury model [22,32,33]. Toxicological studies have shown
that AS601245 exerts no influence on physiological indexes, such as arterial blood pressure,
blood sugar, body temperature, etc. [32]. In this study, JNK activity in the AS601245-treated
cortex was reduced to 41% of the level compared to the DMSO-treated cortex (Fig 3A and 3B),
indicating that JNK activity was blocked by AS601245. Meanwhile, we found that AS601245
treatment obviously increased p-FOXO3a expression (Fig 3C and 3D), which significantly
attenuated FOXO3a in the nucleus but increased its level in the cytoplasm (Fig 3E and 3F).
These findings suggested that AS601245 reduced FOXO3a translocation from the cytoplasm to
the nucleus. The reduction of FOXO3a translocation by JNK inhibition might be mediated via
increased p-FOXO3a.
treated cortex (E). p-Akt and total Akt were not obviously changed at 48 h in the AS601245-treated cortex compared with the DMSO-treated cortex (G).
Quantification of total FOXO3a, p-FOXO3a, FOXO3a nuclear, FOXO3a cytoplasmic, total Akt and p-Akt expression in sham controls, HI, DMSO-, and
AS601245-treated cortices (D, F, and H). The data were obtained by densitometry and normalized to GAPDH as the loading control. The values are
expressed in relative optical density and represented as the mean±SD. For each column, n = 5, *p<0.05, **p<0.01 versus the sham control, #p<0.05,
##p<0.01 compared with DMSO controls (HI, hypoxia-ischemia; AS, AS601245).
doi:10.1371/journal.pone.0132998.g003
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Fig 4. JNK inhibitor AS601245 decreased levels of Bim and CC3 proteins and reduced neuronal apoptosis and brain infarct volume in P7 rat after
HI. Samples were obtained from the cortex. Bim and CC3 protein levels were significantly reduced at 48 h in the AS601245-treated cortex compared with the
DMSO-treated cortex (A). Cell apoptosis was detected by TUNEL staining with the In Situ Cell Death Detection Kit (Merck Millipore) according to the
manufacturer's protocol. Ten fields were chosen randomly at 400x magnification to count the apoptotic and total cells. The apoptotic index (AI) was
calculated as follows: AI = (number of apoptotic cells/total number counted) ×100%. TUNEL-positive cells were not detected in the sham controls (C).
However, the positive cells were increased at 6 h (data not shown) and 24 h (data not shown) and peaked at 48 h (D) after HI. Meanwhile, AS601245
pretreatment obviously reduced cellular apoptosis at 48 h after HI (F) and decreased the infarct volume 7 days after HI significantly (Fig 4H), compared with
the DMSO controls (Fig 4E and 4H,). The cell apoptosis index in the AS601245-treated brain cortex was decreased by 59% compared with the DMSO-
treated brain cortex (Fig 4G). The infarct volume in the AS601245-treated brain was decreased by 58% compared with the DMSO controls (Fig 4I).
doi:10.1371/journal.pone.0132998.g004
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Because FOXO3a is downstream of Akt [12], we questioned whether Akt is involved in the
regulation of JNK/FOXO3a. Surprisingly, we found that JNK inhibition by AS601245 did not
affect the level of p-Akt after HI (Fig 3G and 3H). This finding suggests that the regulation of
FOXO3a phosphorylation and its translocation into the nucleus by the JNK signal pathway
was not mediated by Akt. The mechanism by which JNK regulates FOXO3a in an Akt-
independent manner after HI is not clear. JNK-regulated phosphatase activities may be
involved in the dephosphorylation of FOXO3a [19,20].
The transcription factor FOXO3a can activate Bim gene expression and promote caspase-
independent apoptosis [13]. In addition, the direct effect of JNK on Bim and consequent Bax
translocation to mitochondria are also essential processes to initiate mitochondrial apoptosis
[3]. We further studied whether the inhibition of JNK by AS601245 could downregulate the
expression of Bim and CC3 and decrease cellular apoptosis. We found that AS601245 not only
obviously reduced the expression of Bim and CC3 (Fig 4A and 4B), it also significantly inhib-
ited neuronal apoptosis and reduced brain infarct volume after HI (Fig 4F and 4H). Our find-
ings are consistent with a recent report that showed JNK inhibition may provide
neuroprotection by downregulating Bim after adult ischemic brain injury [3].
In summary, we have shown that the JNK/FOXO3a/Bim pathway is involved in neuronal
apoptosis in the developing rat brain after HI, and JNK’s regulation of FOXO3a may be inde-
pendent of Akt. Agents targeting JNK might provide insight into the protective mechanisms
involved in neonatal HI.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No. 81000262
to Deyuan Li, No. 81330016 and 31171020 to Dezhi Mu; No. 81172174 and 81270724 to Yi
Qu, No. 81100457 to Jinhui Li, and No. 81200462 to Li Zhang), the Major State Basic Research
Development Program (2013CB967404), grants from the Ministry of Education of China
(313037, 20110181130002), a grant from the State Commission of Science Technology of
China (2012BAI04B04), grants from the Science and Technology Bureau of Sichuan province
(2010SZ0280, 2011JTD0005, 2012SZ0150), and the Grant of Clinical Discipline Program
(Neonatology) from the Ministry of Health of China (1311200003303).
Author Contributions
Conceived and designed the experiments: DL XL JW DM YQ. Performed the experiments: JL
LZ TX JT. Analyzed the data: DL DM YQ. Contributed reagents/materials/analysis tools: JL LZ
TX JT. Wrote the paper: DL DM YQ. Provided support with a methodological perspective: YQ.
References
1. Mielke K, Herdegen T (2000) JNK and p38 stresskinases–degenerative effectors of signal-transduction-
cascades in the nervous system. Prog Neurobiol 61:45–60. PMID: 10759064
2. Okuno S, Saito A, Hayashi T, Chan PH (2004) The c-Jun N-terminal protein kinase signaling pathway
mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient
focal cerebral ischemia. J Neurosci 24:7879–7887. PMID: 15356200
3. Gao Y, Signore AP, Yin W, Cao G, Yin XM, Sun F, et al. (2005) Neuroprotection against focal ischemic
brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-
signaling pathway. J Cereb Blood Flow Metab 25:694–712. PMID: 15716857
4. Kuan CY,Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, et al. (2003) A critical role of neural-
specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci U S A 100:15184–15189. PMID: 14657393
5. Greer EL, Brunet A (2005) FOXO transcription factors at the interface between longevity and tumor
suppression. Oncogene 24:7410–7425. PMID: 16288288
Involvement of the JNK/FOXO3a/Bim Pathway in Neuronal Apoptosis
PLOS ONE | DOI:10.1371/journal.pone.0132998 July 14, 2015 13 / 15
6. Bi W, Xiao L, Jia Y, Wu J, Xie Q, Ren J, et al. (2010) c-Jun N-terminal Kinase Enhances MST1-
mediated Pro-apoptotic Signaling through Phosphorylation at Serine 82. J Biol Chem 285:6259–6264.
doi: 10.1074/jbc.M109.038570 PMID: 20028971
7. Birkenkamp KU, Coffer PJ (2003) Regulation of cell survival and proliferation by the FOXO (Forkhead
box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans 31:292–297. PMID:
12546704
8. Arden KC (2007) FoxOs in tumor suppression and stem cell maintenance. Cell 128:235–237. PMID:
17254960
9. Huang H, Tindall DJ (2007) Dynamic FoxO transcription factors. J Cell Sci 120:2479–2487. PMID:
17646672
10. Fu Z, Tindall DJ. FOXOs (2008) cancer and regulation of apoptosis. Oncogene 27:2312–2319. doi: 10.
1038/onc.2008.24 PMID: 18391973
11. Zanella F, Rosado A, Garcia B, Carnero A, Link W (2008) Chemical genetic analysis of FOXO nuclear-
cytoplasmic shuttling by using image-based cell screening. ChemBioChem 9: 2229–2237. doi: 10.
1002/cbic.200800255 PMID: 18756565
12. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. (1999) Akt promotes cell survival by phos-
phorylating and inhibiting a Forkhead transcription factor. Cell 96: 857–868. PMID: 10102273
13. Gilley J, Coffer PJ, Ham J (2003) FOXO transcription factors directly activate bim gene expression and
promote apoptosis in sympathetic neurons. J Cell Biol 162:613–622. PMID: 12913110
14. Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, et al. (2004) FOXO tran-
scription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J
23:4802–4812. PMID: 15538382
15. WangMC, Bohmann D and Jasper H (2005) JNK extends life span and limits growth by antagonizing
cellular and organism-wide responses to insulin signaling. Cell 121:115–125. PMID: 15820683
16. Sunayama J, Tsuruta F, Masuyama N, Gotoh Y (2005) JNK antagonizes Akt-mediated survival signals
by phosphorylating 14-3-3. J Cell Biol 170:295–304. PMID: 16009721
17. Ness JM1, Harvey CA, Strasser A, Bouillet P, Klocke BJ, Roth KA (2006) Selective involvement of BH3-
only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Res. 1099:150–159.
PMID: 16780816
18. Linseman DA, Phelps RA, Bouchard RJ, Le SS, Laessig TA, McClure ML, et al. (2002) Insulin-like
growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signal-
ing in cerebellar granule neurons. J Neurosci 22:9287–9297. PMID: 12417654
19. Yan L, Lavin VA., Moser LR, Cui Q, Kanies C, Yang E (2008) PP2A Regulates the Pro-apoptotic Activ-
ity of FOXO1. J Biol Chem 283:7411–7420. doi: 10.1074/jbc.M708083200 PMID: 18211894
20. Singh A, Ye M, Bucur O, Zhu S, Tanya Santos M, Rabinovitz I, et al. (2010) Protein phosphatase 2A
reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT. Mol Biol Cell 21:1140–1152.
doi: 10.1091/mbc.E09-09-0795 PMID: 20110348
21. Rice JE 3rd, Vannucci RC, Brierley JB (1981) The influence of immaturity on hypoxic-ischemic brain
damage in the rat. Ann Neurol 9:131–141. PMID: 7235629
22. Tu YF, Tsai YS, Wang LW, Wu HC, Huang CC, Ho CJ (2011) Overweight worsens apoptosis, neuroin-
flammation and blood-brain barrier damage after hypoxic ischemia in neonatal brain through JNK
hyperactivation. J Neuroinflammation 25; 8:40. doi: 10.1186/1742-2094-8-40 PMID: 21518436
23. Li L, Qu Y, Li J, Xiong Y, Mao M, Mu D (2007) Relationship between HIF-1alpha expression and neuro-
nal apoptosis in neonatal rats with hypoxia-ischemia brain injury. Brain Res 1180:133–139. PMID:
17920049
24. Liu F, Schafer DP, McCullough LD (2009) TTC, fluoro-Jade B and NeuN staining confirm evolving
phases of infarction induced by middle cerebral artery occlusion. J Neurosci Methods 179:1–8. doi: 10.
1016/j.jneumeth.2008.12.028 PMID: 19167427
25. Khan M, Sekhon B, Giri S, Jatana M, Gilg AG, Ayasolla K (2005) S-nitrosoglutathione reduces inflam-
mation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb
Blood FlowMetab 25:177–192. PMID: 15647746
26. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA., Davidson C, Sharp FR (1990) A semiautomated
method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290–293. PMID: 1689322
27. Frebel K, Wiese S (2006) Signalling molecules essential for neuronal survival and differertiation. Bio-
chem Soc Trans 34:1287–1290. PMID: 17073803
28. Kamada H, Nito C, Endo H, Chan PH (2007) Bad as a converging signaling molecule between survival
PI3-K/Akt and death JNK in neurons after transient focal cerebral ischemia in rats. J Cereb Blood Flow
Metab 27:521–533. PMID: 16820799
Involvement of the JNK/FOXO3a/Bim Pathway in Neuronal Apoptosis
PLOS ONE | DOI:10.1371/journal.pone.0132998 July 14, 2015 14 / 15
29. van den Tweel E. R, Kavelaars A, Lombardi M. S, Nijboer C. H, Groenendaal F, van Bel F, et al. (2006)
Bilateral molecular changes in a neonatal rat model of unilateral hypoxic-ischemic brain damage.
Pediatr. Res 59:434–439. PMID: 16492985
30. Meller R, Cameron JA, Torrey DJ, Clayton CE, Ordonez AN, Henshall DC, et al. (2006) Rapid degrada-
tion of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured
neurons. J Biol Chem 281:7429–7436. PMID: 16431916
31. Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and-independent control of neuro-
nal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11: 297–305. PMID: 11399427
32. Carboni S, Hiver A, Szyndralewiez C, Gaillard P, Gotteland JP, Vitte PA (2004) AS601245(1,3-
benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminalprotein
kinase inhibitor with neuroprotective properties. J Pharmacol Exp Ther 310:25–32. PMID: 14988419
33. Wang LW, Tu YF, Huang CC, Ho CJ (2012) JNK signaling is the shared pathway linking neuroinflam-
mation, blood–brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the
immature brain. J Neuroinflammation 17; 9:175. doi: 10.1186/1742-2094-9-175 PMID: 22805152
Involvement of the JNK/FOXO3a/Bim Pathway in Neuronal Apoptosis
PLOS ONE | DOI:10.1371/journal.pone.0132998 July 14, 2015 15 / 15
